Immunopathogenesis of experimental ulcerative colitis is mediated by eosinophil peroxidase

被引:128
作者
Forbes, E
Murase, T
Yang, M
Matthaei, KI
Lee, JJ
Lee, NA
Foster, PS
Hogan, SP [1 ]
机构
[1] Australian Natl Univ, John Curtin Sch Med Res, Div Mol Biosci, Allergy & Inflammat Res Grp, Canberra, ACT 0200, Australia
[2] Mayo Clin, Scottsdale, AZ 85259 USA
关键词
D O I
10.4049/jimmunol.172.9.5664
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The precise role that individual inflammatory cells and mediators play in the development of gastrointestinal (GI) dysfunction and extraintestinal clinical manifestations of ulcerative colitis (UC) is unknown. In this study, we have used a mouse model of UC to establish a central role for eotaxin and, in turn, eosinophils in the development of the immunopathogenesis of this disease. In this model the administration of dextran sodium sulfate (DSS) induces a prominent colonic eosinophilic inflammation and GI dysfunction (diarrhea with blood and, shortening of the colon) that resembles UC in patients. GI dysfunction was associated with evidence of eosinophilic cytolytic degranulation and the release of eosinophil peroxidase (EPO) into the colon lumen. By using IL-5 or eotaxin-deficient mice, we show an important role for eotaxin in eosinophil recruitment into the colon during experimental UC. Furthermore, using EPO-deficient mice and an EPO inhibitor resorcinol we demonstrate that eosinophil-derived peroxidase is critical in the development of GI dysfunction in experimental UC. These findings provide direct evidence of a central role for eosinophils and EPO in GI dysfunction and potentially the immunopathogenesis of UC.
引用
收藏
页码:5664 / 5675
页数:12
相关论文
共 50 条
  • [21] STUDIES ON EXPERIMENTAL ULCERATIVE COLITIS
    ELCHLEPP, JG
    KIRSNER, JB
    [J]. JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1955, 46 (05): : 812 - 812
  • [22] Treatment of Experimental Ulcerative Colitis
    Lazebnik, L. B.
    Lychkova, A. E.
    Knyazev, O. V.
    [J]. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2012, 153 (06) : 890 - 893
  • [23] Intensified Th9 Response is Associated with the Immunopathogenesis of Active Ulcerative Colitis
    Shohan, Mojtaba
    Sabzevary-Ghahfarokhi, Milad
    Bagheri, Nader
    Shirzad, Hedayatollah
    Rahimian, Ghorbanali
    Soltani, Amin
    Ghatreh-Samani, Mahdi
    Deris, Fatemeh
    Tahmasbi, Kamran
    Shahverdi, Elahe
    Fathollahi, Fereshteh
    [J]. IMMUNOLOGICAL INVESTIGATIONS, 2018, 47 (07) : 700 - 711
  • [24] Ulcerative colitis: Gut microbiota, immunopathogenesis and application of natural products in animal models
    de Paula do Nascimento, Roberto
    da Fonseca Machado, Ana Paula
    Galvez, Julio
    Betim Cazarin, Cinthia Bau
    Marostica Junior, Mario Roberto
    [J]. LIFE SCIENCES, 2020, 258
  • [25] Post-translational tyrosine nitration of eosinophil granule toxins mediated by eosinophil peroxidase
    Ulrich, Martina
    Petre, Alina
    Youhnovski, Nikolay
    Proemm, Franziska
    Schirle, Markus
    Schumm, Michael
    Pero, Ralph S.
    Doyle, Alfred
    Checkel, James
    Kita, Hirohito
    Thiyagarajan, Nethaji
    Acharya, K. Ravi
    Schmid-Grendelmeier, Peter
    Simon, Hans-Uwe
    Schwarz, Heinz
    Tsutsui, Masato
    Shimokawa, Hiroaki
    Bellon, Gabriel
    Lee, James J.
    Przybylski, Michael
    Doering, Gerd
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (42) : 28629 - 28640
  • [26] Downregulated eosinophil activity in ulcerative colitis with concomitant primary sclerosing cholangitis
    Lampinen, Maria
    Fredricsson, Annika
    Vessby, Johan
    Martinez, Johana Fernandez
    Wanders, Alkwin
    Rorsman, Fredrik
    Carlson, Marie
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 2018, 104 (01) : 173 - 183
  • [27] Serum eosinophil cationic protein in active and quiescent ulcerative colitis.
    Linskens, RK
    Pronk-Admiraal, CJ
    Van Bodegraven, AA
    Bartels, PCM
    Tuynman, HARE
    [J]. GASTROENTEROLOGY, 1998, 114 (04) : A1023 - A1023
  • [28] Inhibition of spontaneous and immunoglobulin E mediated eosinophil secretory activity in Gastrointestinal allergy (GA) and ulcerative colitis (UC) by budesonide
    Raithel, M
    Weidenhiller, M
    Winterkamp, S
    Schneider, T
    Hochberger, J
    Hahn, EG
    [J]. GASTROENTEROLOGY, 1999, 116 (04) : A920 - A920
  • [29] Differential expression of Fcgamma-receptor mediated eosinophil activity in Crohn's disease (CD) and ulcerative colitis (UC).
    Raithel, M
    Winterkamp, S
    Hochberger, J
    Hahn, EG
    [J]. GASTROENTEROLOGY, 1998, 114 (04) : A1066 - A1066
  • [30] EXPERIMENTAL ULCERATIVE COLITIS BY BACTERIAL IMMUNISATION
    ZWEIBAUM, A
    MORARD, JC
    HALPERN, B
    [J]. PATHOLOGIE BIOLOGIE, 1968, 16 (19-2): : 813 - +